Lexeo Therapeutics Inc. Common Stock (LXEO) Insider Trading
- $4,999,995.00
- $615,938.50
- Nov. 11, 2024
- Richard Nolan Townsend
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Nov. 11, 2024 | CEO | 2,500 | $7.82 | Sell | $19,550.00 | |
| Oct. 10, 2024 | CEO | 5,000 | $8.10 | Sell | $40,500.00 | |
| Sept. 10, 2024 | CEO | 5,000 | $10.65 | Sell | $53,250.00 | |
| Aug. 12, 2024 | CEO | 5,000 | $11.53 | Sell | $57,650.00 | |
| July 10, 2024 | CEO | 26,969 | $16.50 | Sell | $444,988.50 | |
| Nov. 7, 2023 | Major Shareholder | 454,545 | $11.00 | Buy | $4,999,995.00 |
Insiders are both buying and selling Lexeo Therapeutics Inc. Common Stock stock.
The insider traders at Lexeo Therapeutics Inc. Common Stock are: Richard Nolan Townsend, and Fund Vi L.P. Omega
The most active insider trader at Lexeo Therapeutics Inc. Common Stock is Richard Nolan Townsend with 5 trades.
Richard Nolan Townsend has sold the most Lexeo Therapeutics Inc. Common Stock stock with a total value of $635,488.50.
Fund Vi L.P. Omega has bought the most Lexeo Therapeutics Inc. Common Stock stock with a total value of $9,999,990.00.
The most recent insider trade for Lexeo Therapeutics Inc. Common Stock was on Nov. 11, 2024.
The single biggest insider buy for Lexeo Therapeutics Inc. Common Stock was from Fund Vi L.P. Omega with a total value of $4,999,995.00 on Nov. 7, 2023.
The single biggest insider sell for Lexeo Therapeutics Inc. Common Stock was from Richard Nolan Townsend with a total value of $444,988.50 on July 10, 2024.